Correction to: A Predictive Biomarker Model Using Quantitative Electroencephalography in Adolescent Major Depressive Disorder,by McVoy,et al. J Child Adolesc Psychopharmacol 2022;32(9):460–466;doi: 10.1089/cap.2022.0041

In the November 2022 issue of Journal of Child and Adolescent Psychopharmacology (vol. 32, no. 9; 460–466), the article entitled “A Predictive Biomarker Model Using Quantitative Electroencephalography in Adolescent Major Depressive Disorder,” by McVoy et al. requires correction.

In the original article, the number of major depressive disorder (MDD) participants was incorrectly listed as 35 in the Abstract section.

“qEEG data and psychometric measures were obtained in adolescents aged 14–17 years with MDD (n = 35) and age and gender-matched HCs (n = 14).”

The correct number of participants should have been listed as 21 so that it reads:

“qEEG data and psychometric measures were obtained in adolescents aged 14–17 years with MDD (n = 21) and age and gender-matched HCs (n = 14).”

The online version of the article has been corrected to reflect this. The authors apologize for the error.